![Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41584-021-00726-8/MediaObjects/41584_2021_726_Fig1_HTML.png)
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
![The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology](https://www.jacionline.org/cms/asset/e4e0edfa-47b0-4dac-9e26-86e52ebf2400/gr1.jpg)
The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology
![A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future? - Liu - 2021 - Arthritis & Rheumatology - Wiley Online Library A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future? - Liu - 2021 - Arthritis & Rheumatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c7e946c6-d795-4371-929f-e8d1c041ae8e/art41906-fig-0001-m.jpg)
A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future? - Liu - 2021 - Arthritis & Rheumatology - Wiley Online Library
Overview of small molecule inhibitors targeting the p38 MAPK pathway... | Download Scientific Diagram
![Cancers | Free Full-Text | Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies? Cancers | Free Full-Text | Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?](https://www.mdpi.com/cancers/cancers-13-02611/article_deploy/html/images/cancers-13-02611-g001.png)
Cancers | Free Full-Text | Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?
![Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//15782190/0000011200000006/v1_202106020933/S1578219021001499/v1_202106020933/en/main.assets/gr2.jpeg?xkr=ue/ImdikoIMrsJoerZ+w91sAmkCw32Jed9sZf6jzEuDbFpW7G0NfARZs8afh+9K8v8RN+oFy2ZmalFHXVYo6Aie+UNYu+1x4/+PZwM2be6gocu7je7Ivd84aP9yuUpAp5loSwhZmq8oNXID6H82uEikcfFdF2G31vbHz00Cfzl7z4ZKHDmb7be34AeK94496U2UX8LWCzW9Nf+YIS85tJBvN1THIFUjKEGcObk5KMrRSVGB77Owae6S7TGBbYxiRymiXY1+XbjGCSIBvv7tTJDTaHR1yY0u5sMKBguuDaM0=)
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
![Safety of Janus kinase (JAK) inhibitors in the short‐term treatment of atopic dermatitis - Wood - 2022 - International Journal of Dermatology - Wiley Online Library Safety of Janus kinase (JAK) inhibitors in the short‐term treatment of atopic dermatitis - Wood - 2022 - International Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/f302ae52-1766-4f3d-87c7-b62be74fdf60/ijd15853-fig-0001-m.jpg)
Safety of Janus kinase (JAK) inhibitors in the short‐term treatment of atopic dermatitis - Wood - 2022 - International Journal of Dermatology - Wiley Online Library
![Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases | Journal of Medicinal Chemistry Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.9b00533/asset/images/medium/jm9b00533_0025.gif)
Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases | Journal of Medicinal Chemistry
![Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661816307137-fx1.jpg)
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect
![Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology](https://www.gastrojournal.org/cms/asset/80839385-b019-483a-93f6-59ca4fc6809c/gr1.jpg)
Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology
![A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokine–related JAK-STAT signal | Science Advances A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokine–related JAK-STAT signal | Science Advances](https://www.science.org/cms/10.1126/sciadv.abo4363/asset/23e53306-8cfe-42ea-9f0b-cd545b9364ed/assets/images/large/sciadv.abo4363-f1.jpg)
A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokine–related JAK-STAT signal | Science Advances
![Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists](https://www.frontiersin.org/files/MyHome%20Article%20Library/437721/437721_Thumb_400.jpg)
Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists
![A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-023-00892-5/MediaObjects/13555_2023_892_Fig1_HTML.png)
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink
![Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata | Actas Dermo-Sifiliográficas Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata | Actas Dermo-Sifiliográficas](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//00017310/0000011200000006/v1_202106081644/S0001731020305548/v1_202106081644/es/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w91sAmkCw32Jed9sZf6jzEuDbFpW7G0NfARZs8afh+9K8v8RN+oFy2ZmalFHXVYo6Aie+UNYu+1x4/+PZwM2be6gocu7je7Ivd84aP9yuUpAp5loSwhZmq8oNXID6H82uEikcfFdF2G31vbHz00Cfzl7z4ZKHDmb7be34AeK94496U2UX8LWCzW9Nf+YIS85tJBvN1THIFUjKEGcObk5KMrRSVGB77Owae6S7TGBbYxiRymiXY1+XbjGCSIBvv7tTJDTaHR1yY0u5sMKBguuDaM0=)